Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Clinical Pharmacology and Therapeutics
|
September 10, 2010
Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol
S von Haehling, S M Bode-Böger, J Martens-Lobenhoffer, et al.
Journal of the American College of Cardiology
|
August 14, 2001
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone
S D Anker, M Volterrani, C D Pflaum, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 25, 2013
Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis
T Szabó, N Scherbakov, A Sandek, et al.
European Journal of Endocrinology
|
November 27, 2001
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia
W Doehner, C D Pflaum, M Rauchhaus, et al.
Neurological Research and Practice
|
March 18, 2026
Correction: Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience
V Mafael, T Buck, H Stengl, et al.
ESC Heart Failure
|
October 7, 2016
Validation of the FEW16 questionnaire for the assessment of physical well-being in patients with heart failure with reduced ejection fraction: results from the CIBIS-ELD study
E Tahirović, D J Lashki, T D Trippel, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 18, 2015
Request for regulatory guidance for cancer cachexia intervention trials
Kch Fearon, J M Argiles, V E Baracos, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Clinical Pharmacology and Therapeutics
|
September 10, 2010
Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol
S von Haehling, S M Bode-Böger, J Martens-Lobenhoffer, et al.
Journal of the American College of Cardiology
|
August 14, 2001
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone
S D Anker, M Volterrani, C D Pflaum, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 25, 2013
Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis
T Szabó, N Scherbakov, A Sandek, et al.
European Journal of Endocrinology
|
November 27, 2001
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia
W Doehner, C D Pflaum, M Rauchhaus, et al.
Neurological Research and Practice
|
March 18, 2026
Correction: Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience
V Mafael, T Buck, H Stengl, et al.
ESC Heart Failure
|
October 7, 2016
Validation of the FEW16 questionnaire for the assessment of physical well-being in patients with heart failure with reduced ejection fraction: results from the CIBIS-ELD study
E Tahirović, D J Lashki, T D Trippel, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 18, 2015
Request for regulatory guidance for cancer cachexia intervention trials
Kch Fearon, J M Argiles, V E Baracos, et al.
Page
of 4